ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Lee Untitled risk score Newly admitted patients with a primary diagnosis of heart failure Female %: 50.5 Family origin: Not reported Setting: 14 hospitals Country: Canada Participants were recruited previous to 2001 Mortality at 1 year AUC Mortality at 1 Retrospective cohort Levy Seattle Heart Failure Model years and NYHA class II to IV heart failure Age (years): 71.7 7 Male %: 69 Family origin not reported Setting: Multicentre Country: 46 countries Follow-up not reported Participants were recruited previous to 2001 survival free from LVAD or transplantati on ROC Survival (free from LVAD or transplantati on) at 1 year: RENAISSANC Val-HeFT: IN-CHF: Retrospective analysis of cohort and RCT data RENAISSANCE People with EF 30% and NYHA class II to IV heart failure Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Age (years): 62 12 Male %: 78 Family origin not reported Setting: Multicentre Country: USA and Canada Follow-up not reported Participants were recruited previous to 2001 Val-HeFT People with EF 40% and NYHA class II to IV heart failure Age (years): 63 11 Male %: 80 Family origin not reported Setting: Multicentre Country: 16 countries Follow-up not reported Participants were recruited previous to 2001 IN-CHF People with heart failure of any etiology, age, EF or comorbidity Age (years): 64 12 Male %: 76 Family origin not reported Setting: Multicentre Country: Italy Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. 